CTLA4 anticorps (AA 36-161)
Aperçu rapide pour CTLA4 anticorps (AA 36-161) (ABIN5541119)
Antigène
Voir toutes CTLA4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 36-161
-
Specificité
- This antibody detects CTLA4 at aa 36-161.
-
Purification
- Protein-A affinity chromatography
-
Immunogène
- Recombinant human CTLA4 (36-161aa) purified from E. coli
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- ELISA. Western blot: Recommended starting dilution is 1:3000. Immunocytochemistry / Immunoflourescence. Flow cytometry.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4 containing 0.02 % Sodium Azide and 10 % Glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store undiluted at 2-8°C for up to two weeks or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Date de péremption
- 12 months
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Autre désignation
- cd152,ctla4
-
Sujet
- CTLA4 (Cytotoxic T-Lymphocyte Antigen 4), also known as CD152, is a protein receptor that downregulates the immune system. CTLA4 is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Mutations in CTLA4 have been associated with insulin-dependent diabetes mellitus, Graves' disease, Hashimoto's thyroiditis, celiac disease and other autoimmune diseases.
-
UniProt
- P16410
-
Pathways
- Cancer Immune Checkpoints
Antigène
-